Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
17 November, 2018 06:06 IST
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA
Source: IRIS | 12 Jul, 2018, 01.23PM
Comments  |  Post Comment

Cadila Healthcare announced that the manufacturing facility of Zydus Hopsira Oncology, a 50:50 joint venture company between Zydus Cadila and Hospira Inc., USA (now part of Pfizer Group) at Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA which concluded that the inspection is "closed" and states that the inspection classification of this facility is 'Voluntary Action Indicated' (VAI). The manufacturing plant had completed the USFDA audit from April 5 to 12, 2018.

Shares of the company declined Rs 3, or 0.81%, to trade at Rs 368.50. The total volume of shares traded was 107,976 at the BSE (1.09 p.m., Thursday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Welspun Corp bags large order for supply of pipes for oil & gas project - 16-Nov-2018 15:36
Bharat Electronics pays Rs 644.1mn dividend to Govt of India - 16-Nov-2018 10:09
Shilpa Medicare gets tentative nod for Dimethyl Fumarate capsules - 16-Nov-2018 10:01
NIIT Tech partners with R3 to build solutions on Corda platform - 16-Nov-2018 09:42
Glenmark Pharma gets USFDA approval for Teriflunomide tablets - 16-Nov-2018 09:36
Steel Strips Wheels bags export order for EU caravan market - 15-Nov-2018 15:33
Lupin receives USFDA approval for Decitabine for injection - 15-Nov-2018 12:00
Zydus Cadila receives USFDA nod for Arsenic Trioxide injection - 15-Nov-2018 10:11
ICICI Bank raises retail term-deposit interest rates by upto 25bps - 15-Nov-2018 09:55
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer